CLINICAL_TRIALS
trial_result
· 2013-05-22
Clinical Trial Update: ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 trial update of ABI-007 in combination with bevacizumab for metastatic breast cancer; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-05-22